Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: A Study in Patients With Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 clinical trial for chronic obstructive pulmonary disease sponsored by Chiesi Farmaceutici S.p.A. has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: A Comprehensive Care Programme for Patients With Chronic Obstructive Pulmonary Disease [NA]
This document reports a completed clinical trial evaluating a comprehensive care programme for patients with chronic obstructive pulmonary d…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Tiotropium Respimat Versus HandiHaler on SaO2 and Sleep in COPD Patients [NA]
A completed clinical trial compared tiotropium delivered by the Respimat inhaler versus the HandiHaler in chronic obstructive pulmonary dise…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: A Study in Patients With Chronic Obstructive Pulmonary Disease (FAIR) [Phase 3]
A Phase 3 COPD trial (FAIR) sponsored by Chiesi Farmaceutici has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Study to Investigate the Effect of Formoterol vs Salmeterol on Small Airways Physiological Parameters in COPD Patients [Phase 4]
A Phase 4 clinical trial comparing formoterol versus salmeterol on small airways physiological parameters in patients with chronic obstructi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Safety, Tolerability and Efficacy of 28-day Inhaled CHF 6001 DPI in COPD Patients [Phase 2]
A Phase 2 trial evaluating the safety, tolerability, and efficacy of a 28-day inhaled CHF 6001 dry powder inhaler in patients with chronic o…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary Disease [NA]
A terminated clinical trial evaluating the effect of QVAR (beclomethasone dipropionate) on lung function in chronic obstructive pulmonary di…
-
CLINICAL_TRIALS withdrawal · 2017-03-29Clinical Trial Update: Escitalopram in Anxiety Associated Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [Phase 3]
A Phase 3 trial evaluating escitalopram for anxiety in COPD exacerbations has been withdrawn. No results were reported.
-
CLINICAL_TRIALS withdrawal · 2017-03-29Clinical Trial Update: Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels [Phase 2]
A Phase 2 exploratory study of omalizumab (Xolair) in chronic obstructive pulmonary disease patients with elevated IgE levels has been withd…
-
CLINICAL_TRIALS research · 2017-03-29Clinical Trial Update: Evaluating Genes in Sputum to Measure Drug Response in COPD [NA]
A National Jewish Health-sponsored COPD trial evaluating sputum gene expression as a biomarker for drug response has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2) [Phase 3]
Phase 3 PINNACLE 2 trial evaluating the efficacy and safety of PT003, PT005, and PT001 in adults with moderate to very severe COPD has compl…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Effect of Statins on Asthma Control in Smokers With Asthma [Phase 2]
A Phase 2 clinical trial evaluating whether statins can improve asthma control in smokers with asthma has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1) [Phase 3]
A Phase 3 PINNACLE 1 trial update reports on the efficacy and safety of PT003, PT005, and PT001 in patients with moderate to very severe chr…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease [Phase 2]
Phase 2 trial update for Batefenterol/Fluticasone Furoate in chronic obstructive pulmonary disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Flutiform® Compared With Seretide® in the Treatment of COPD [Phase 2, Phase 3]
A completed Phase 2/3 trial compared Flutiform with Seretide for treating chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Autologous Bronchial Basal Cells Transplantation for Treatment of Chronic Obstructive Pulmonary Disease (COPD) [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating autologous bronchial basal cell transplantation as a treatment for chronic obstructive pulmonary di…
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: An Investigation Of The Interaction Of GSK961081 With Inhaled Beta-Agonist And Anti-Muscarinic Drugs. [Phase 2]
Phase 2 trial investigating interaction of GSK961081 with inhaled beta-agonist and antimuscarinic drugs in chronic obstructive pulmonary dis…
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 dose-finding trial of batefenterol (GSK961081) inhaled via dry powder inhaler in COPD was completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272) [Phase 4]
A Phase 4 trial comparing tiotropium bromide alone versus tiotropium bromide with formoterol fumarate in chronic obstructive pulmonary disea…
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial comparing the fixed-dose combination aclidinium bromide/formoterol fumarate to the individual components (aclidinium bromide a…
-
CLINICAL_TRIALS research · 2017-03-23Clinical Trial Update: Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints
A completed clinical trial aimed at longitudinally identifying predictive surrogate endpoints for chronic obstructive pulmonary disease (COP…
-
FDA approval · 2017-03-22FDA Approved: UMECLIDINIUM AND VILANTEROL ELLIPTA — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Umeclidinium and Vilanterol Ellipta (umeclidinium bromide and vilanterol trifenatate) submitted …
-
CLINICAL_TRIALS research · 2017-03-22Clinical Trial Update: Long - Term Respiratory Rehabilitation Programs in Chronic Obstructive Pulmonary Disease. [NA]
This clinical trial update describes long-term respiratory rehabilitation programs for chronic obstructive pulmonary disease. The study stat…
-
CLINICAL_TRIALS withdrawal · 2017-03-22Clinical Trial Update: Home Mechanical Ventilation in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Hypercapnic Response [NA]
A clinical trial investigating home mechanical ventilation in patients with chronic obstructive pulmonary disease and hypercapnic response h…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Inhalation Therapy in Ambulant and Hospitalized Patient Using Available Film Sequences From the Internet
A completed clinical trial evaluating inhalation therapy in ambulatory and hospitalized patients, sponsored by RWTH Aachen University, using…